Hoth Therapeutics Ownership | Who Owns Hoth Therapeutics?

Hoth Therapeutics Ownership Summary

0.92% insiders, and 99.08% retail investors. Planned solutions is the largest institutional shareholder, holding 0% of HOTH shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.56% of its assets in Hoth Therapeutics shares.

HOTH Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Hoth Therapeutics	-	0.92%	99.08%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Planned solutions	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Planned solutions	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Planned solutions	-	-	-1.00

Top Sellers

Holder	Shares	% Assets	Change
Planned solutions	-	-	-1.00

Sold Out

Holder	Change
Planned solutions	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	1	-	1	-	-	-	1	-	-	-
Dec 31, 2023	2	-	8	-	-	473950.00%	-	-100.00%	-	-
Sep 30, 2023	2	100.00%	8	14.29%	-	286433.33%	1	-	-	-
Jun 30, 2023	1	-	7	-	-	333333.33%	-	-	-	-
Mar 31, 2023	1	-	7	-	-	333333.33%	-	-100.00%	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	38.80K	0.56%	-
Fidelity Extended Market Index	35.55K	0.51%	-286.00
Fidelity Nasdaq Composite Index	31.71K	0.46%	-
Fidelity Total Market Index	16.17K	0.23%	-
Fidelity Series Total Market Index	8.72K	0.13%	-
Spartan Total Market Index Pool E	3.51K	0.05%	-
NT Ext Equity Mkt Idx Fd - NL	1.62K	0.02%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	1.28K	0.02%	-21.00
State St US Extended Mkt Indx NL Cl C	1.08K	0.02%	-
SSgA U.S. Extended Market Index Class I	1.08K	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 16, 2024	Knie Robb	CEO and President	Buy	$16.75K
Sep 19, 2022	Knie Robb	CEO and President	Buy	$3.90K
Sep 16, 2022	Knie Robb	CEO and President	Buy	$4.00K
May 26, 2020	Hayes Anthony	-	Sell	-
May 26, 2020	Hayes Anthony	-	Sell	$500.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q3	1	-
2024 Q1	-	-
2023 Q3	-	-
2022 Q4	-	-

HOTH Ownership FAQ

Who Owns Hoth Therapeutics?

Hoth Therapeutics shareholders are primarily institutional investors at 0%, followed by 0.92% insiders and 0% retail investors. The average institutional ownership in Hoth Therapeutics's industry, Biotech Stocks , is 109.70%, which Hoth Therapeutics falls below.

Does Blackrock own Hoth Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Hoth Therapeutics.

Who is Hoth Therapeutics’s biggest shareholder by percentage of total assets invested?

Planned solutions is Hoth Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Hoth Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Hoth Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Hoth Therapeutics shares, with 0.56% of its total shares outstanding invested in 38.8K Hoth Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools